According to Elanco's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.80469. At the end of 2023 the company had a P/S ratio of 1.66.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.66 | 26.45% |
2022 | 1.31 | -53.35% |
2021 | 2.82 | -36.27% |
2020 | 4.42 | 23.6% |
2019 | 3.58 | -4.83% |
2018 | 3.76 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.8637 | -52.14% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 90.1 | 4,895.17% | ๐บ๐ธ USA |